Vanina de Verneuil

CIK: 0002036234

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)11 (84.6%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (15.4%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

VIR

Vir Biotechnology, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (13 total)

VIR
Vir Biotechnology, Inc.
Feb 25, 2026
Sale(S)
Direct
13.7K shares at avg. $9.82$135K
VIR
Vir Biotechnology, Inc.
Feb 24, 2026
Sale(S)
Direct
3.1K shares at avg. $9.53$30K
VIR
Vir Biotechnology, Inc.
Feb 23, 2026
Sale(S)
Direct
4.4K shares at avg. $7.45$33K
VIR
Vir Biotechnology, Inc.
Feb 22, 2026
Award(A)
Direct
55K shares-
VIR
Vir Biotechnology, Inc.
Nov 5, 2025
Sale(S)
Direct
2.4K shares at avg. $5.16$12K
VIR
Vir Biotechnology, Inc.
Nov 3, 2025
Sale(S)
Direct
1.4K shares at avg. $5.86$8K
VIR
Vir Biotechnology, Inc.
Feb 26, 2025
Sale(S)
Direct
7.4K shares at avg. $9.14$67K
VIR
Vir Biotechnology, Inc.
Feb 24, 2025
Sale(S)
Direct
5.1K shares at avg. $9.45$49K
VIR
Vir Biotechnology, Inc.
Feb 22, 2025
Award(A)
Direct
35K shares-
VIR
Vir Biotechnology, Inc.
Dec 2, 2024
Sale(S)
Direct
76 shares at avg. $8.22$624.728
VIR
Vir Biotechnology, Inc.
Nov 6, 2024
Sale(S)
Direct
4.4K shares at avg. $10.11$44K
VIR
Vir Biotechnology, Inc.
Nov 5, 2024
Sale(S)
Direct
2.3K shares at avg. $9.47$22K
VIR
Vir Biotechnology, Inc.
Nov 1, 2024
Sale(S)
Direct
1.4K shares at avg. $7.20$10K

		Type	Shares	Price		Ownership
Feb 25, 2026	VIR Vir Biotechnology, Inc.	Sale(S)	13,700	$9.82	$134,534	Direct
Feb 24, 2026	VIR Vir Biotechnology, Inc.	Sale(S)	3,117	$9.53	$29,713	Direct
Feb 23, 2026	VIR Vir Biotechnology, Inc.	Sale(S)	4,445	$7.45	$33,128	Direct
Feb 22, 2026	VIR Vir Biotechnology, Inc.	Award(A)	55,000	-	$0	Direct
Nov 5, 2025	VIR Vir Biotechnology, Inc.	Sale(S)	2,385	$5.16	$12,307	Direct
Nov 3, 2025	VIR Vir Biotechnology, Inc.	Sale(S)	1,365	$5.86	$8,003	Direct
Feb 26, 2025	VIR Vir Biotechnology, Inc.	Sale(S)	7,373	$9.14	$67,402	Direct
Feb 24, 2025	VIR Vir Biotechnology, Inc.	Sale(S)	5,140	$9.45	$48,590	Direct
Feb 22, 2025	VIR Vir Biotechnology, Inc.	Award(A)	35,000	-	-	Direct
Dec 2, 2024	VIR Vir Biotechnology, Inc.	Sale(S)	76	$8.22	$625	Direct
Nov 6, 2024	VIR Vir Biotechnology, Inc.	Sale(S)	4,397	$10.11	$44,454	Direct
Nov 5, 2024	VIR Vir Biotechnology, Inc.	Sale(S)	2,347	$9.47	$22,225	Direct
Nov 1, 2024	VIR Vir Biotechnology, Inc.	Sale(S)	1,403	$7.20	$10,107	Direct

1-13 of 13 transactions

About de Verneuil Vanina

de Verneuil Vanina (SEC CIK 0002036234) files insider reports with the SEC as EVP, General Counsel, Corp Sec of Vir Biotechnology, Inc. (VIR).

Signal8 holds 10 ownership filings by de Verneuil Vanina (1 Form 3, 9 Form 4), filed between Oct 2, 2024 and Feb 26, 2026. Those filings report 13 transactions, from Nov 1, 2024 to Feb 25, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on de Verneuil Vanina's filings is in SAN FRANCISCO, CA.

Recent filings by de Verneuil Vanina

Feb 25, 2026: Open-market sale of VIR shares (Form 4, code S).
Feb 24, 2026: Open-market sale of VIR shares (Form 4, code S).
Feb 23, 2026: Open-market sale of VIR shares (Form 4, code S).
Feb 22, 2026: Grant or award of VIR shares (Form 4, code A).
Nov 5, 2025: Open-market sale of VIR shares (Form 4, code S).

Other insiders filing for Vir Biotechnology, Inc. (VIR)

Topalian Suzanne Louise, Director
Sawaf Aziz, EVP, Chief Financial Officer
MORE ROBERT J, Director
Coughlin Timothy, Director
Napolitano Janet, Director
Sabatini Brent, SVP, Chief Accounting Officer

How to read Form 4 transaction codes